Related Experiment Video

Updated: Aug 14, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Osteosarcoma: basic science and clinical implications

James B Hayden1, Bang H Hoang

  • 1Department of Orthopedics and Rehabilitation, Oregon Health & Science University, Portland, 97239, USA.

The Orthopedic Clinics of North America
|November 29, 2005
PubMed

Insights

Identifying patients with poor responses to osteosarcoma treatment is crucial. New biologic markers and therapeutic targets, like growth factors, are being explored to improve outcomes for these individuals.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Current osteosarcoma therapies are effective for 60-70% of patients.
  • Identifying non-responders to standard treatment is a significant clinical challenge.
  • Existing research explores biologic markers and gene expression patterns for treatment stratification.

Purpose of the Study:

  • To investigate novel therapeutic targets for osteosarcoma.
  • To identify potential biomarkers for predicting treatment response.
  • To develop strategies for managing patients with poor prognoses.

Main Methods:

  • Evaluation of growth factors, chemokines, transcription factors, and angiogenic factors.
  • Analysis of microarray data for patient stratification.
  • Review of current therapeutic approaches and their limitations.

Main Results:

  • Several new molecular targets show promise in osteosarcoma.
  • Biomarkers for predicting treatment response are under investigation.
  • Understanding these targets may lead to personalized treatment strategies.

Conclusions:

  • New therapeutic targets offer potential for treating osteosarcoma patients resistant to standard therapy.
  • Further research into these targets could improve patient outcomes.
  • Personalized medicine approaches are essential for optimizing osteosarcoma treatment.

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...